3628 results for «69»
3628 results
TAVI and complex coronary artery anatomy
18 Feb 2023 – From PCR Tokyo Valves 2023
What defines 'complex TAVI and coronary artery scenarios'? Join this session to discover when chimney stenting for threatening left coronary artery obstruction becomes the ideal alternative, using balloon-assisted BASILICA for valve-in-valve TAVR, and addressing tissue embolisation post-TAVI.
Mutual understanding of essential roles of co-medical staff supporting structural heart disease intervention
18 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session in japanese to learn more about the essential roles of co-medicals in structural heart disease intervention: the decision-making regarding the treatment and imaging procedure, strategies and evaluating effects and complications.
Mitral valve interventions
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover various compelling mitral valve interventions in this session: newer vs. older generations of the MitraClip devices, safety and feasibility of balloon mitral valvotomy, catheter ablation efficacy, and more!
Complication and bailout of TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
As TAVI is never risk-free, learn about bailout techniques to counter various complications. This session explores cases such as failure to release aortic stenosis after implantation of a self-expanding valve, retrieving a pigtail catheter straightener dropped into aorta and balloon rupture during TAVI.
Transcatheter edge-to-edge repair for challenging situations
19 Feb 2023 – From PCR Tokyo Valves 2023
Explore various innovative repairs repairs: MitraClip for degenerative regurgitation, TEER bridge therapy, successful combined MitraClip and TriClip procedure, and simultaneous mitral repair with LAA closure.
The role and benefit of WATCHMAN FLX in stroke prevention
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, discover WATCHMAN FLX's numerous benefits for stroke prevention, covering topics such as patient indications for LAAC, the importance of Heart-Brain Team collaboration and post-procedural management insights.
PFO closure
17 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to learn procedural tips and tricks and explore the role of PFO treatment for stroke prevention. Discover the evidence for PFO closure, when it should be considered, pre, intra and post procederal management, and common procedural complications.
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 9
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
AICT-AsiaPCR 2023 Opening Ceremony
21 Sep 2023 – From AICT-AsiaPCR 2023
This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
